script.reportAU
Register
← The record

Influenza Vaccine, Injection

Noted OtherNational Immunisation ProgramNot applicable line

Universal vaccination against influenza of all persons aged 65 years and older.

1
Submissions
2009–09
On the record
—
ICER range
Cost-min
Cost basis

Decisions on record

10 decisions
  • Meeting Mar 2026 Noted Prevention of influenza no PSD
  • Meeting Jul 2025 Withdrawn Prevention of influenza no PSD
  • Meeting Jul 2025 Recommended Prevention of influenza no PSD
  • Meeting Mar 2024 Recommended Prevention of influenza in children aged 6 months to <5 years
  • Meeting Mar 2024 Recommended Prevention of influenza in people aged 65 years and over
  • Meeting Nov 2009 Recommended Vaccine for Influenza no PSD
  • Meeting Jul 2009 Recommended Influenza virus
  • Meeting Apr 2008 Recommended Influenza vaccination no PSD
2 earlier decisions
  • Nov 2007 Not recommended Influenza
  • Mar 2007 Recommended Vaccine no PSD

Access path

1 submission · public record
  1. Jul 2009
    Recommended · restricted

    vs 15 microgram intramuscular (IM) influenza vaccines…

  2. PBS listing · National Immunisation Program
RecommendedDeferredNot recommended

Cost-effectiveness

Cost-minimisation analysis; no ICER calculated as economic evaluation was based on cost-minimisation rather than cost-effectiveness

The PBAC recommended the listing of the influenza intradermal (ID) vaccine on the NIP on the basis of cost-minimisation versus the intramuscular (IM) vaccine. PBAC · 2009
Cost-effectiveness accepted

Decision context

Populationpersons aged 65 years and older

Submission history

1 entries
DecidedOutcomeComparatorICEREvidence
Jul 2009 Recommended · restricted 15 microgram intramuscular (IM) influenza vaccines (Vaxigrip) — RCT · seroprotection rates, geometric mean titres (GMT)

Similar precedents

By decision profile
Inactivated Trivalent Influenza Vaccine (Split Virion)85%Inactivated Trivalent Influenza Vaccine (Split Virion), High Dose81%Influenza Vaccine, Adjuvanted80%Influenza Vaccine, Adjuvanted Quadrivalent And Adjuvanted Trivalent79%Inactivated Trivalent Influenza Vaccine (Surface Antigen), Adjuvanted79%Quadrivalent Influenza Vaccine79%Influenza Vaccine78%Quadrivalent Recombinant Influenza Vaccine78%

Regulatory · TGA

Label equal than PBS population — Both TGA label and PBAC recommendation specify identical population: universal vaccination of all persons aged 65 years and older.